{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":18,"n_cols":5,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[10,2,10,3],[11,2,11,3],[15,2,15,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910789030303321"]
[null,null,"Autore",null,"Ryvlin Philippe"]
[null,null,"Titolo",null,"From first unprovoked seizure to newly diagnosed epilepsy / / Philippe Ryvlin [and three others]"]
[null,null,"Pubbl/distr/stampa",null,"Montrouge : , : John Libbey Eurotext, , [2007]"]
[{"$nulls":4},"©2007"]
[null,null,"ISBN",null,"2-7420-0927-2"]
[null,null,"Descrizione fisica",null,"1 online resource (237 p.)"]
[null,null,"Collana",null,"Progress in epileptic disorders, , 1777-4284 ; ; volume 3"]
[null,null,"Soggetti",null,"Epilepsy - Research"]
[{"$nulls":4},"Convulsions"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"\"\"Natural evolution of first unprovoked epileptic seizure\"\"\"\"Risk factors for developing epilepsy after a first unprovoked seizure\"\"; \"\"Section III: Epileptogenesis and disease progression: the example of febrile seizures\"\"; \"\"â€œComplexâ€? febrile seizures and the epilepsy: information from an experimental model\"\"; \"\"Section IV: Novel approaches of medical risk factors for unprovoked seizures and cryptogenic epilepsy\"\"; \"\"Comorbidity of epilepsy and neuropsychiatric disorders: epidemiological considerations\"\"; \"\"Commentary by Andres M. Kanner\"\""]
[{"$nulls":4},"\"\"Epileptic seizures in the context of the dysimmune syndromes\"\"\"\"Section V: From randomized controlled trials to patient-oriented decision making\"\"; \"\"From randomised controlled trials to patient-oriented therapy: methodology and clinical issues\"\"; \"\"Treatment of first unprovoked seizure\"\"; \"\"Treatment of newly diagnosed epilepsy\"\"; \"\"Bridging the gap between clinical guidelines and individualized patient treatment\"\"; \"\"Section VI: Future Challenges\"\"; \"\"What types of trials and studies do we need for early treatment of epilepsy?\"\""]
[{"$nulls":4},"\"\"From prediction of medical intractability to early surgical treatment\"\""]